245 related articles for article (PubMed ID: 20543091)
1. Role of iNOS and peroxynitrite-matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats.
Bencsik P; Kupai K; Giricz Z; Görbe A; Pipis J; Murlasits Z; Kocsis GF; Varga-Orvos Z; Puskás LG; Csonka C; Csont T; Ferdinandy P
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H512-8. PubMed ID: 20543091
[TBL] [Abstract][Full Text] [Related]
2. Direct renin inhibition with aliskiren protects against myocardial ischemia/reperfusion injury by activating nitric oxide synthase signaling in spontaneously hypertensive rats.
Zhang W; Han Y; Meng G; Bai W; Xie L; Lu H; Shao Y; Wei L; Pan S; Zhou S; Chen Q; Ferro A; Ji Y
J Am Heart Assoc; 2014 Jan; 3(1):e000606. PubMed ID: 24473199
[TBL] [Abstract][Full Text] [Related]
3. Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition.
Giricz Z; Lalu MM; Csonka C; Bencsik P; Schulz R; Ferdinandy P
J Pharmacol Exp Ther; 2006 Jan; 316(1):154-61. PubMed ID: 16166272
[TBL] [Abstract][Full Text] [Related]
4. The Cardioprotective Effects of Late-Phase Remote Preconditioning of Trauma Depends on Neurogenic Pathways and the Activation of PKC and NF-κB (But Not iNOS) in Mice.
Song Y; Ye YJ; Li PW; Zhao YL; Miao Q; Hou DY; Ren XP
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):310-9. PubMed ID: 26450997
[TBL] [Abstract][Full Text] [Related]
5. Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult.
Huang C; Cui Y; Ji L; Zhang W; Li R; Ma L; Xing W; Zhou H; Chen B; Yu J; Zhang H
Pharm Biol; 2013 Apr; 51(4):463-73. PubMed ID: 23336403
[TBL] [Abstract][Full Text] [Related]
6. The role of peroxynitrite in chemical preconditioning with 3-nitropropionic acid in rat hearts.
Turan N; Csonka C; Csont T; Giricz Z; Fodor G; Bencsik P; Gyöngyösi M; Cakici I; Ferdinandy P
Cardiovasc Res; 2006 May; 70(2):384-90. PubMed ID: 16443208
[TBL] [Abstract][Full Text] [Related]
7. Late protective effect of pharmacological preconditioning with total flavones of rhododendra against myocardial ischemia-reperfusion injury.
Zhang JH; Chen ZW; Wu Z
Can J Physiol Pharmacol; 2008 Mar; 86(3):131-8. PubMed ID: 18418440
[TBL] [Abstract][Full Text] [Related]
8. Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective.
Bencsik P; Pálóczi J; Kocsis GF; Pipis J; Belecz I; Varga ZV; Csonka C; Görbe A; Csont T; Ferdinandy P
Pharmacol Res; 2014 Feb; 80():36-42. PubMed ID: 24380772
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive limb ischemic preconditioning protects against myocardial I/R injury in rats.
Li SJ; Wu YN; Kang Y; Yin YQ; Gao WZ; Liu YX; Lou JS
J Surg Res; 2010 Nov; 164(1):162-8. PubMed ID: 19726056
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress.
Tao L; Gao E; Jiao X; Yuan Y; Li S; Christopher TA; Lopez BL; Koch W; Chan L; Goldstein BJ; Ma XL
Circulation; 2007 Mar; 115(11):1408-16. PubMed ID: 17339545
[TBL] [Abstract][Full Text] [Related]
11. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2.
Dawn B; Xuan YT; Guo Y; Rezazadeh A; Stein AB; Hunt G; Wu WJ; Tan W; Bolli R
Cardiovasc Res; 2004 Oct; 64(1):61-71. PubMed ID: 15364614
[TBL] [Abstract][Full Text] [Related]
12. Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury.
Wildhirt SM; Weismueller S; Schulze C; Conrad N; Kornberg A; Reichart B
Cardiovasc Res; 1999 Aug; 43(3):698-711. PubMed ID: 10690341
[TBL] [Abstract][Full Text] [Related]
13. The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats.
Sato H; Bolli R; Rokosh GD; Bi Q; Dai S; Shirk G; Tang XL
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2557-64. PubMed ID: 17704286
[TBL] [Abstract][Full Text] [Related]
14. [Morphine-induced late cardioprotection: potential role of inducible nitric oxide synthase].
Shi EY; Jiang XJ; Bai H; Nakajima Y
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):891-5. PubMed ID: 15329271
[TBL] [Abstract][Full Text] [Related]
15. Carbon monoxide increases inducible NOS expression that mediates CO-induced myocardial damage during ischemia-reperfusion.
Meyer G; André L; Kleindienst A; Singh F; Tanguy S; Richard S; Obert P; Boucher F; Jover B; Cazorla O; Reboul C
Am J Physiol Heart Circ Physiol; 2015 Apr; 308(7):H759-67. PubMed ID: 25595132
[TBL] [Abstract][Full Text] [Related]
16. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.
Mukhopadhyay P; Rajesh M; Bátkai S; Kashiwaya Y; Haskó G; Liaudet L; Szabó C; Pacher P
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1466-83. PubMed ID: 19286953
[TBL] [Abstract][Full Text] [Related]
17. Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts.
Kocsis GF; Pipis J; Fekete V; Kovács-Simon A; Odendaal L; Molnár E; Giricz Z; Janáky T; van Rooyen J; Csont T; Ferdinandy P
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2406-9. PubMed ID: 18359895
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits.
Takano H; Manchikalapudi S; Tang XL; Qiu Y; Rizvi A; Jadoon AK; Zhang Q; Bolli R
Circulation; 1998 Aug; 98(5):441-9. PubMed ID: 9714095
[TBL] [Abstract][Full Text] [Related]
19. A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70.
Yin C; Salloum FN; Kukreja RC
Circ Res; 2009 Mar; 104(5):572-5. PubMed ID: 19213952
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
